Radiation and Chemical Defense Working Group
|
Committee, Advisory Group, or Work Group
|
ASPR, FDA
|
NIEHS, NIAMS
|
2020
|
|
Radiation Biodosimetry Working Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAID
|
2012
|
|
Radiobiology Bioterrorism Research and Training Group (RABRAT)
|
Committee, Advisory Group, or Work Group
|
FDA, ASPR
|
NIAID
|
2003
|
|
Rapid Acceleration of Diagnostics Tech Program (RADx Tech)
|
Research Initiative
|
CMS, FDA, CDC, ASPR
|
NIBIB
|
2020
|
|
Rare Disease Day at NIH
|
Meeting/ Workshop
|
FDA
|
NCATS, NHLBI, NCI, CC, NIAAA, NINDS
|
2011
|
|
Rare Diseases Registry Program (RaDaR)
|
Research Initiative
|
FDA
|
NCATS
|
|
|
Reciprocal Educational and Training Partnerships between FDA/CDER and the NIH Clinical Center
|
Training Initiative
|
FDA
|
CC, NCI, NIAID, NIDCR, NIDDK, NIMH, NINDS
|
2007
|
|
Recognize, Assist, Include, Support and Engage (RAISE) Family Caregiving Advisory Council
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, CDC, CMS, FDA, HRSA, IHS, SAMHSA
|
NIA
|
2018
|
|
Regenerative Medicine Innovation Project Senior Oversight Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCATS, NEI, NHLBI, NIA, NIAID, NIAMS, NIDCD, NIDCR, NIDDK, NINDS
|
2018
|
|
Regenerative Medicine Project
|
Research Initiative
|
FDA
|
NIA
|
2017
|
|
Registry-based studies of hematologic malignancy incidence and survivorship
|
Research Initiative
|
FDA
|
|
2019
|
|
Regulation of Virulence Genes in Bordetella pertussis
|
Research Initiative
|
FDA
|
NIDDK
|
|
|
Rheumatic and Autoimmune Diseases in Minority Communities
|
Research Initiative
|
FDA
|
NIAMS
|
|
|
Role of Class B Scavenger Receptors in Lipid Metabolism and Inflammation
|
Research Initiative
|
FDA
|
CC
|
|
|
Role of Gs-alpha in pancreatic islet cell growth and function
|
Research Initiative
|
FDA
|
NIDDK
|
|
|